Literature DB >> 25366295

Prostate cancer: immunoPET for imaging disease progression in prostate cancer.

Rebecca Kelsey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25366295     DOI： 10.1038/nrurol.2014.304

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Applications of immunoPET: using 124I-anti-PSCA A11 minibody for imaging disease progression and response to therapy in mouse xenograft models of prostate cancer.

Authors:  Scott M Knowles; Richard Tavaré; Kirstin A Zettlitz; Matthew M Rochefort; Felix B Salazar; Ziyue Karen Jiang; Robert E Reiter; Anna M Wu
Journal:  Clin Cancer Res       Date:  2014-10-17       Impact factor: 12.531
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.